ReviewExploration of targeted anti-tumor therapy2022

Myeloid cell leukemia-1: a formidable barrier to anticancer therapeutics and the quest of targeting it.

Prasad Sulkshane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.